# Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery

Source: https://onco.cc/trials/nct03579602/  
OnCo record `nct03579602` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2/3 trial of Tozuleristide run by Blaze Bioscience Inc., completed.

## Summary

Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery is a phase 2/3 interventional study registered as NCT03579602 by Blaze Bioscience Inc., with 118 participants enrolled, started 2018-11-26. Conditions recorded: Pediatric Central Nervous System Tumor. Interventions recorded: tozuleristide and Canvas System.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT03579602
- Phase: 2/3
- Setting: A Randomized, Blinded Study of Fluorescence Detection of Pediatric Primary Central Nervous System Tumors in Subjects Receiving Tozuleristide and Imaged With the Canvas System
- Sponsor: Blaze Bioscience Inc.
- Enrolled: 118

## Sources

- ClinicalTrials.gov NCT03579602: https://clinicaltrials.gov/study/NCT03579602

## Connected records

- cancers: [Brain and spinal cord tumours (all types)](https://onco.cc/cancers/brain-tumours/)
- drugs: [Tozuleristide](https://onco.cc/drugs/blz-100/)
- companies: [Blaze Bioscience](https://onco.cc/companies/blaze-bioscience/)

---
JSON: https://onco.cc/api/v1/entities/nct03579602.json